Loading clinical trials...
Loading clinical trials...
PHASE II STUDY OF MINI-CHOP PLUS OFATUMUMAB (O) IN NON PREVIOUSLY TREATED PATIENTS AGED OVER 80 YEARS WITH CD 20+ DIFFUSE LARGE B-CELL LYMPHOMA
Conditions
Interventions
Ofatumumab
Locations
84
Belgium
Zna Stuivenberg
Antwerp, Belgium
RHMS
Baudour, Belgium
Az Sint Jan Av
Bruges, Belgium
Institut Jules Bordet
Brussels, Belgium
Universite Libre de Bruxelles - Hopital Erasme
Brussels, Belgium
Ucl de Louvain St Luc
Brussels, Belgium
Start Date
May 1, 2010
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
March 7, 2018
Lead Sponsor
The Lymphoma Academic Research Organisation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions